Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Coloplast Director's Dealing 2016

Feb 18, 2016

3358_rns_2016-02-18_e3a89150-fda6-45c6-94e4-a1288f5e573c.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

C

Coloplast

Ostomy care

Urology & Continence care

Wound & Skin care

Nasdaq Nordic

18 February 2016

Coloplast A/S

Holtedam 1

DK-3050 Humlebæk

Denmark

Tel: +45 4911 1111

www.coloplast.com

CVR No. 69749917

Report on transactions of executives and related parties in Coloplast shares and related securities

According to the Danish Securities Act § 28a Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.

The below transaction concerns sales of shares.

Name Martin Giørtz Müller
Reason Member of the board
Issuer Coloplast A/S
ISIN code DK0060448595
Description Shares
Transaction Sale
Trade date 18 February 2016
Market Nasdaq Nordic
Number 100
Share price in DKK 524.00
Market value in DKK 52,400

Kind regards,

Coloplast A/S

Ellen Bjurgert

This information is available in Danish and in English, in case of doubt the Danish version prevails.

For further information: Ellen Bjurgert, tel. +45 4911 3376.